SurModics
SRDX
$33.33
Share price
29.74%
Change (1 day)
44.98%
Change (1 year)
Categories
SurModics (SRDX) - Total debt
Total debt on the balance sheet as of December 2023 : $33.87 M
According to SurModics's latest financial reports the company's total debt is $33.87 M. A company’s total debt is the sum of all current and non-current debts.
SurModics - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $33.25 M | 124.58% |
| 2022-09-30 | $14.8 M | 8.03% |
| 2021-09-30 | $13.7 M | 262.98% |
| 2020-09-30 | $3.77 M | |
| 2019-09-30 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 86,486.37% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 46,032.96% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $34.91 B | 102,972.97% | 🇺🇸 USA |
 Agilent Technologies A | $2.55 B | 7,442.21% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 13,212.67% | 🇺🇸 USA |
 Alkermes ALKS | $0.37 B | 998.67% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.11 B | 247.67% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.17 B | 430.25% | 🇺🇸 USA |
 Enzo Biochem ENZ | $7.18 M | -78.80% | 🇺🇸 USA |